Neuronetics, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 |
|---|---|---|---|
| Revenue | $52.8M | $40.4M | $34.2M |
| Cost of Revenue | $12.4M | $9.6M | $6.6M |
| Gross Profit | $40.3M | $30.8M | $27.6M |
| Gross Margin | 76.4% | 76.2% | 80.7% |
| Operating Expenses | |||
| Research & Development | $8.2M | $7.9M | $8.2M |
| SG&A Expense | $13.7M | $8.6M | $6.9M |
| Operating Income | $-19.8M | $-13.6M | $-9.3M |
| Operating Margin | -37.6% | -33.7% | -27.3% |
| Interest Expense | $3.7M | $2.8M | $1.8M |
| Pretax Income | $-24.1M | $-16.1M | $-11.2M |
| Income Tax Expense | — | — | — |
| Net Income | $-24.1M | $-16.1M | $-11.2M |
| Net Margin | -45.7% | -39.7% | -32.8% |
| EPS (Basic) | $-1.35 | $-43.17 | $-38.48 |
| EPS (Diluted) | $-1.35 | $-43.17 | $-38.48 |
| Shares Outstanding (Basic) | 35.5M | 462.0K | — |
| Shares Outstanding (Diluted) | 35.5M | 462.0K | — |
| Dividends Per Share | — | — | — |